GlassScriptPhysician profile
Samuel M Valle
NPI 1700315025
$7,657.40
in general payments reported to CMS, 2019-2025
6 companies · $491 in 2025
The $491 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,351 · 2022: $2,035 · 2023: $492 · 2024: $3,289 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,443 · Travel and Lodging: $1,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,443.46 |
| Travel and Lodging | $1,828.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,095.79 | 2021-2025 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Penumbra, INC. | $2,156.74 | 2023-2025 | Indigo System |
| Philips North America LLC | $1,891.74 | 2023-2025 | (Bh4) Igt Devices Undivided, (Az7) Lasers, Labosys |
| Siemens Medical Solutions USA, INC. | $359.55 | 2022 | |
| Boston Scientific Corporation | $108.53 | 2022 | |
| Terumo Medical Corporation | $45.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Valle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.